DIFFERENT MODES OF ACTION OF TWO ANTIOVULATORY COMPOUNDS

1964 ◽  
Vol 45 (4_Suppl) ◽  
pp. S179-S190 ◽  
Author(s):  
G. A. Overbeek ◽  
J. de Visser
Keyword(s):  
Luteinizing Hormone ◽  
Pituitary Gland ◽  
Single Injection ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
List Type ◽  
Modes Of Action ◽  
Final Maturation ◽  
Site Of Action ◽  
Lh Release

ABSTRACT Lynestrenol and 6α-methyllynestrenol were studied in rats for their respective ability to: prevent spontaneous ovulation. prevent ovulation induced by a single injection of luteinizing hormone (human chorionic gonadotrophin). to prevent ovarian hypertrophy in parabiotic (♀[unk]) rats The results warrant the following conclusions about the site of action of both substances: Lynestrenol prevents ovulation by inhibiting FSH release from the pituitary gland, so that there are no ripening follicles ready to respond to LH. 6α-Methyllynestrenol inhibits ovulation by abolishing LH-release thus preventing the final maturation and rupture of normally developing follicles.

EFFECTS OF CONTINUOUS LIGHT ON THE REPRODUCTIVE CYCLE OF THE FEMALE RAT: INDUCTION OF OVULATION AND PITUITARY GONADOTROPHINS DURING PERSISTENT OESTRUS

1967 ◽  
Vol 38 (4) ◽  
pp. 389-394 ◽  
Author(s):  
K. B. SINGH ◽  
G. S. GREENWALD
Keyword(s):  
Luteinizing Hormone ◽  
Single Injection ◽  
Follicle Stimulating Hormone ◽  
Continuous Light ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
The Other ◽  
Constant Light ◽  
Female Rat ◽  
Control Light

SUMMARY The majority of rats exposed to constant light for approximately 6 weeks ovulated within 24 hr. after an injection of human chorionic gonadotrophin (HCG), but required 24–48 hr. after a single injection of progesterone. This suggests that HCG acted directly on the ovary but that progesterone acted indirectly by way of the hypothalamo-hypophysial system. Animals injected with progesterone after 6 weeks of constant light failed to ovulate after single or spaced injections of progesterone at 90 days of constant light while HCG administration was still effective. Pituitary content and concentration of luteinizing hormone (LH) in constant-light animals (duration of constant light: 45 days) were below normal pituitary levels during prooestrus and were in the range of normal oestrous values. On the other hand, follicle-stimulating hormone (FSH) content and concentration were similar to those in cyclic rats. Single injections of 1 mg. progesterone changed neither LH nor FSH concentration, despite the fact that such treatment induced ovulation. Bilateral ovariectomy increased both LH and FSH content and concentration in constant-light animals to the same extent as in control light—dark animals.

GONADOTROPHIN REQUIREMENTS FOR IMPLANTATION IN THE MOUSE

1971 ◽  
Vol 50 (1) ◽  
pp. 19-27 ◽  
Author(s):  
B. M. BINDON
Keyword(s):  
Luteinizing Hormone ◽  
Half Life ◽  
Single Injection ◽  
Follicle Stimulating Hormone ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Suckling Mice ◽  
Rat Pituitary ◽  
Pituitary Glands ◽  
Pregnant Mare Serum Gonadotrophin

SUMMARY Gonadotrophins were injected into mated hypophysectomized and suckling mice in an attempt to induce implantation. In these two classes of animal implantation is normally delayed by absence or suppression of pituitary gonadotrophin release. Antibodies raised against ovine gonadotrophins were injected into mice soon after mating in an attempt to inhibit implantation. Pregnant mare serum gonadotrophin (PMSG) was effective in inducing implantation in both hypophysectomized and in suckling mice. This may mean that a gonadotrophin with the qualities of PMSG normally initiates implantation. Alternatively, PMSG may have been effective by virtue of its long half-life rather than any special hormonal attributes. Human chorionic gonadotrophin was ineffective in both types of mouse. Mixtures of ovine follicle-stimulating hormone (FSH) and luteinizing hormone (LH) (100 μg of each), injected daily for 3 days, were necessary to induce implantation in hypophysectomized mice. Implantation was readily induced in suckling mice by a single injection of FSH (equivalent to 12·5 μg NIH-FSH-S3) prepared from rat pituitary glands. Implantation was readily inhibited by anti-ovine LH. Anti-ovine FSH was ineffective but this did not cross-react with mouse FSH.

MECHANISM OF THE SELECTIVE SURGE OF FOLLICLE-STIMULATING HORMONE IN DIOESTROUS RATS DURING THE INDUCTION OF OVULATION BY HUMAN CHORIONIC GONADOTROPHIN

1980 ◽  
Vol 86 (3) ◽  
pp. 489-495 ◽  
Author(s):  
SHUJI SASAMOTO ◽  
KAZUYOSHI TAYA
Keyword(s):  
Luteinizing Hormone ◽  
Follicle Stimulating Hormone ◽  
Time Of Day ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Normal Cycle ◽  
Luteinizing Hormone Releasing Hormone ◽  
Immature Rats ◽  
Lh Release ◽  
Lh Rh

A selective surge of FSH with a small concomitant rise in LH occurred invariably in rats when ovulation was induced by injecting human chorionic gonadotrophin (HCG) at various reproductive stages such as day 15 of lactation and in 29-day-old immature rats as well as in dioestrous animals. No FSH surge occurred on day 3 of lactation or in 26-day-old immature rats in which ovulation could not be induced by HCG. The FSH surge occurred 6–18 h after HCG treatment regardless of the time of day of injection of HCG. Ovulation began by 12 h and was completed by 18 h after injection of HCG. Pituitary responsiveness to luteinizing hormone releasing hormone (LH-RH) with respect to FSH release strikingly increased at 01.00 h on day 1 after HCG injection at 17.00 h of dioestrus (day 0) to levels similar to those of the group at 01.00 h of oestrus, when the greatest response was noted during the normal cycle. With regard to LH release pituitary responsiveness to LH-RH at 01·00 h on day 1 markedly increased but the response was only about half of the response at 01·00 h of oestrus and one third of the response at 17.00 h of pro-oestrus when the greatest response was noted during the normal oestrous cycle. These results indicate that during ovulation the pituitary gland of the rat is highly responsive to LH-RH with respect to the release of FSH, for which secretory changes in the ovary after an ovulating dose of HCG may be responsible.

THE PRECISION OF THE OVARIAN ASCORBIC ACID DEPLETION TEST FOR LUTEINIZING HORMONE

1963 ◽  
Vol 43 (1) ◽  
pp. 155-160
Author(s):  
Jørgen Falck Larsen ◽  
Christian Hamburger
Keyword(s):  
Ascorbic Acid ◽  
Luteinizing Hormone ◽  
Clinical Analysis ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin

ABSTRACT Various modifications of the Parlow test for luteinizing hormone (ovarian ascorbic acid depletion in rats) were tried. Human chorionic gonadotrophin was used instead of hypophyseal luteinizing hormone. The precision of the method was found to be so low, however, that the test could not be used for routine clinical analysis. The low precision found in this and other laboratories is thought to be due to the strains of rats used.

AUGMENTATION BY CHLORMADINONE OF THE UTERINE WEIGHT RESPONSE TO HUMAN CHORIONIC GONADOTROPHIN IN INTACT IMMATURE RATS

1965 ◽  
Vol 33 (3) ◽  
pp. 447-454
Author(s):  
M. J. K. HARPER
Keyword(s):  
Single Injection ◽  
Direct Action ◽  
Follicular Development ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Female Rats ◽  
Uterine Weight ◽  
Control Value ◽  
Orally Active ◽  
Stimulation Of

SUMMARY Administration of chlormadinone, an orally active progestational agent without significant oestrogenic activity, to intact immature female rats did not affect either ovarian or uterine weight significantly compared with controls. A single injection of human chorionic gonadotrophin (HCG) caused a 73 % increase in uterine weight in 24 hr. over the control value. This dose significantly increased ovarian weight and although it caused some stimulation of follicular development, ovulation during this time did not occur. When animals were treated with chlormadinone for 8 days, and received HCG on the 8th day, uterine weight was 170% greater than in the controls and 56% greater than with HCG alone. The uterine weight produced was similar to that found in animals treated with mestranol, a potent oestrogen, and HCG. In ovariectomized animals HCG did not affect uterine weight, while the small increase produced by chlormadinone was unaltered when HCG also was given. Mechanisms are discussed by which this augmentation of the uterine response to HCG might be produced. It seems most likely that chlormadinone administration causes storage of endogenous gonadotrophin in the pituitary, and that the exogenous gonadotrophin acts as the 'trigger' for the release of stored hormone, probably by a direct action on the hypothalamus.

ANTIGONADOTROPHIC PROFILE OF ANTISERA AGAINST HUMAN GONADOTROPHIN PREPARATIONS

1971 ◽  
Vol 67 (2) ◽  
pp. 262-276 ◽  
Author(s):  
P. Petrusz ◽  
C. Robyn ◽  
E. Diczfalusy
Keyword(s):  
Biological Activity ◽  
Luteinizing Hormone ◽  
Total Dose ◽  
Follicle Stimulating Hormone ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Immunological Activity ◽  
Human Menopausal Gonadotrophin ◽  
Stimulating Hormone

ABSTRACT Forty-two antisera were prepared in rabbits against human chorionic gonadotrophin (HCG), human hypophysial gonadotrophin (HHG), human urinary luteinizing hormone (LH) and human menopausal gonadotrophin (HMG) preparations. The gonadotrophic profiles of the antigens were previously characterized by bioassay, immunoassay and bioimmunoassay methods. The 25 most potent antisera were tested in statistically valid bioassays for their HCG and follicle stimulating hormone (FSH) neutralizing activities as well as for their neutralizing potencies against the FSH-like activity present in HCG preparations. The anti-HCG/anti-FSH ratios of the anti-HCG sera tested varied between 6.2 and > 254, while those of the anti-HHG, anti-LH and anti-HMG sera were close to 2. It was found that the total dose of immunological activity (anti-HCG neutralizing and anti-FSH neutralizing potency) rather than that of the biological activity administered to the rabbits was decisive for obtaining antisera with high anti-HCG and anti-FSH titers. Immunization with a highly purified HCG preparation (> 17 000 IU/mg) resulted in antisera exhibiting lower anti-HCG/anti-FSH ratios than did immunization with partially purified preparations. A highly purified urinary LH preparation which did not contain any detectable FSH activity gave rise to antisera exhibiting anti-HCG/anti-FSH ratios of approximately 2.0. These highly purified HCG and LH preparations were shown previously to possess high anti-FSH neutralizing potencies (Petrusz et al. 1971b). Booster injections did not change significantly the quality or the titer of the antigonadotrophic sera studied. The HCG neutralizing potency of anti-HCG sera was approximately 3 times higher when assayed against a highly purified HCG preparation (> 17 000 IU/mg) as compared to potency estimates obtained against the laboratory standard of HCG (about 2000 IU/mg). It is suggested that consideration should be given to the establishment of standard preparations of antigonadotrophic sera. It is concluded that bioimmunoassays are more suitably than conventional bioassay methods for the assessment of the antigenic purity of human gonadotrophin preparations.

The induction of puberty in rapidly-grown gilts

1984 ◽  
Vol 1984 ◽  
pp. 84-84 ◽  
Author(s):  
N. Walker ◽  
P. J. Burnett
Keyword(s):  
Single Injection ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Mating Pattern ◽  
Exogenous Hormones ◽  
Alternative Stimulus

Puberty can be stimulated from about 160 days of age by the introduction of a mature boar usually in accomodation which is novel to the gilt. The interval between stimulation and response is not always predictable and therefore does not facilitate the synchronisation of gilt matings with the mating pattern in an established sow herd. It has been reported previously that a single injection of pregnant mares’ serum gonadotrophin (PMSG) pits human chorionic gonadotrophin (HCG)* will initiate puberty. The investigations reported here concern the use of these exogenous hormones as an additional or alternative stimulus to those described above.

INHIBITION BY MELATONIN OF THE PITUITARY RESPONSE TO LUTEINIZING HORMONE RELEASING HORMONE IN VIVO

1978 ◽  
Vol 76 (3) ◽  
pp. 487-491 ◽  
Author(s):  
K. YAMASHITA ◽  
M. MIENO ◽  
T. SHIMIZU ◽  
ER. YAMASHITA
Keyword(s):  
Luteinizing Hormone ◽  
Carotid Artery ◽  
Anterior Pituitary ◽  
Chorionic Gonadotrophin ◽  
Human Chorionic Gonadotrophin ◽  
Luteinizing Hormone Releasing Hormone ◽  
Releasing Hormone ◽  
Lh Rh ◽  
Lh Secretion

The rate of secretion of 17-oxosteroids by the testes of anaesthetized dogs in vivo was used as an index of LH secretion. Intracarotid injection of luteinizing hormone releasing hormone (LH-RH, 1, 5 or 10 μg/kg body wt) resulted in an increase in the testicular 17-oxosteroid secretion which was roughly proportional to the dose administered and which reached a maximum 60 min after the injection. Testicular output of 17-oxosteroids was unaffected by administration of melatonin (10 or 100 μg/kg body wt) into the carotid artery. When LH-RH (5 μg/kg) was injected into the carotid artery 3 h after intracarotid injection of melatonin (10 or 100 μg/kg), the testicular response to LH-RH was considerably diminished. Pretreatment with melatonin (100 μg/kg) did not alter the testicular response to human chorionic gonadotrophin (20 i.u./kg body wt) given i.v. It is concluded that melatonin may act directly on the anterior pituitary gland in dogs to inhibit the LH-RH-induced release of LH.

Sign in / Sign up

Export Citation Format

Share Document